news
Why ageing must become central to Parkinson’s research
An international team of scientists is urging researchers to put ageing at the centre of Parkinson’s studies, arguing that it has been overlooked for too long.
List view / Grid view
Neurosciences
news
New SHANK3 conditional knockout mouse model launched for PMS research
A new SHANK3 conditional knockout mouse model from InnoSer, CureSHANK and Ozgene has been launched to advance research into Phelan-McDermid syndrome, other neurodevelopmental disorders and the development of new therapies.
news
Alcohol addiction linked to major brain gene changes
New research shows chronic alcohol use rewires gene activity in human brain regions that control reward and decision-making, which could inform the development of more effective addiction treatments.
news
How Epstein-Barr virus could trigger multiple sclerosis
New research has demonstrated how a common virus may trigger the immune attack that leads to multiple sclerosis, providing a deeper look into a disease that affects nearly one million people in the US.
news
Targeting mGlu7 could lead to new anxiety and PTSD treatments
Addex Therapeutics has published new research showing that targeting the mGlu7 receptor with a negative allosteric modulator can disrupt fear memory reconsolidation, offering a potential new approach to treating anxiety and PTSD.
news
New psilocybin data highlights challenges for anorexia drug development
New preclinical research shows that psilocybin’s behavioural and inflammatory effects vary with metabolic state and exercise, highlighting key biological variables that could inform drug discovery, target selection and patient stratification in psychedelic therapeutics.
news
Tau protein changes reveal new targets for neurodegenerative diseases
New research has revealed that tau-driven neurodegenerative diseases each have distinct chemical signatures, challenging current one-size-fits-all approaches to diagnosis and treatments.
news
New 3D brain organoids reveal how glioblastoma evades treatment
Researchers have developed 3D human brain organoids that reveal how glioblastoma interacts with brain and immune cells, discovering hidden drivers of tumour invasion.
news
New blood test could detect Parkinson’s years before symptoms
Scientists have identified early blood biomarkers for Parkinson’s disease, revealing a narrow window in which the condition could be detected years before symptoms appear.
webinar
What it takes to automate high-content imaging at scale
30 January 2026 | By Yokogawa
This webinar examines the design trade-offs and technical constraints involved in building a high-throughput robotic imaging pipeline for complex biological workflows.
news
CC023 mice reveal how ALS can develop after viral infections
Researchers have discovered a mouse strain that mirrors ALS in humans following a viral infection, offering new insights into how the disease develops, potentially opening new pathways for early diagnosis and drug development.
news
Brain discovery could improve drugs targeting amyloid diseases
New research shows the brain can intentionally form amyloids to store memories, challenging decades of thinking about neurodegenerative disease and pointing towards new strategies for drug discovery.
news
Targeting cPLA2 enzyme may reduce brain inflammation in Alzheimer’s
Researchers have identified new drug candidates that selectively target the cPLA2 enzyme, a key driver of brain inflammation linked to Alzheimer’s disease, offering a potential new approach to reducing risk in people with the APOE4 gene.
news
HIV drug Maraviroc could be used to slow glioblastoma growth
Researchers have discovered how seemingly supportive brain cells help glioblastoma thrive, whilst identifying an existing HIV drug, Maraviroc, that could be repurposed to slow tumour growth.
news
How ageing cells affect brain development and neurodegeneration
New research has revealed how cellular senescence – the process in which ageing cells change function – shapes human brain structure from development to old age, improving our understanding of brain ageing and neurodegenerative diseases.
